- Home
- VCYT vs WT Comparison
VCYT vs WT Comparison
Compare VCYT & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCYT
- WT
- Stock Information
- Founded
- VCYT 2006
- WT 1985
- Country
- VCYT United States
- WT United States
- Employees
- VCYT 824
- WT N/A
- Industry
- VCYT Medical Specialities
- WT Investment Bankers/Brokers/Service
- Sector
- VCYT Health Care
- WT Finance
- Exchange
- VCYT Nasdaq
- WT Nasdaq
- Market Cap
- VCYT 2.4B
- WT 1.9B
- IPO Year
- VCYT 2013
- WT N/A
- Fundamental
- Price
- VCYT $30.22
- WT $13.40
- Analyst Decision
- VCYT Buy
- WT Buy
- Analyst Count
- VCYT 9
- WT 5
- Target Price
- VCYT $39.89
- WT $12.48
- AVG Volume (30 Days)
- VCYT 2.4M
- WT 3.7M
- Earning Date
- VCYT 08-06-2025
- WT 07-31-2025
- Dividend Yield
- VCYT N/A
- WT 0.90%
- EPS Growth
- VCYT N/A
- WT N/A
- EPS
- VCYT 0.34
- WT 0.40
- Revenue
- VCYT $479,129,000.00
- WT $444,568,000.00
- Revenue This Year
- VCYT $12.57
- WT $11.62
- Revenue Next Year
- VCYT $10.23
- WT $10.76
- P/E Ratio
- VCYT $90.02
- WT $33.07
- Revenue Growth
- VCYT 19.91
- WT 15.43
- 52 Week Low
- VCYT $22.61
- WT $7.47
- 52 Week High
- VCYT $47.32
- WT $13.79
- Technical
- Relative Strength Index (RSI)
- VCYT 67.14
- WT 61.27
- Support Level
- VCYT $26.61
- WT $11.64
- Resistance Level
- VCYT $30.73
- WT $13.69
- Average True Range (ATR)
- VCYT 1.17
- WT 0.32
- MACD
- VCYT 0.75
- WT -0.04
- Stochastic Oscillator
- VCYT 93.47
- WT 81.86
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime. The Company conducts business under a single operating segment as an ETP sponsor and asset manager.